Squarepoint’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.9M | Buy |
2,211,675
+2,129,150
| +2,580% | +$24M | 0.03% | 347 |
|
|
2025
Q1 | $833K | Buy |
+82,525
| New | +$833K | ﹤0.01% | 1615 |
|
|
2024
Q3 | – | Sell |
-47,579
| Closed | -$503K | – | 2960 |
|
|
2024
Q2 | $503K | Buy |
47,579
+6,091
| +15% | +$64.4K | ﹤0.01% | 1722 |
|
|
2024
Q1 | $437K | Sell |
41,488
-71,338
| -63% | -$752K | ﹤0.01% | 1740 |
|
|
2023
Q4 | $1.27M | Buy |
112,826
+25,237
| +29% | +$283K | ﹤0.01% | 1248 |
|
|
2023
Q3 | $1.02M | Buy |
+87,589
| New | +$1.02M | ﹤0.01% | 1288 |
|
|
2023
Q2 | – | Sell |
-54,174
| Closed | -$400K | – | 2757 |
|
|
2023
Q1 | $400K | Sell |
54,174
-17,112
| -24% | -$126K | ﹤0.01% | 1560 |
|
|
2022
Q4 | $570K | Buy |
71,286
+46,646
| +189% | +$373K | ﹤0.01% | 1391 |
|
|
2022
Q3 | $79K | Sell |
24,640
-2,076
| -8% | -$6.66K | ﹤0.01% | 1913 |
|
|
2022
Q2 | $109K | Sell |
26,716
-89,209
| -77% | -$364K | ﹤0.01% | 1857 |
|
|
2022
Q1 | $573K | Buy |
+115,925
| New | +$573K | ﹤0.01% | 1427 |
|